Search results for "Umbilical"

showing 10 items of 331 documents

Raloxifene increases the capacity of serum to promote prostacyclin release in human endothelial cells: implication of COX-1 and COX-2.

2004

OBJECTIVE Prostacyclin is a potent vasodilator synthesized by two isoforms of cyclooxygenase in endothelium. The aim of this study was to investigate the effect of serum from postmenopausal women treated with raloxifene on prostacyclin production by human umbilical vein endothelial cells and on cyclooxygenases-1 and -2. DESIGN Serum was collected from 21 women receiving 60 mg/day of raloxifene, at baseline and at 3 and 6 months. Human umbilical vein endothelial cells were exposed to serum for 24 hours, and prostacyclin production was evaluated in supernatants. Selective inhibitors of cyclooxygenases-1 and -2 (SC-560 and NS-398) were used to investigate the relative contribution of each enzy…

Selective Estrogen Receptor Modulatorsmedicine.medical_specialtyUmbilical VeinsEndotheliumCell SurvivalProstacyclinVasodilationUmbilical veinWestern blotInternal medicinemedicineHumansRaloxifeneCyclooxygenase InhibitorsCells CulturedNitrobenzeneschemistry.chemical_classificationSulfonamidesbiologymedicine.diagnostic_testCyclooxygenase 2 Inhibitorsbusiness.industryObstetrics and GynecologyEndothelial CellsMembrane ProteinsMiddle AgedEpoprostenolImmunohistochemistryIsoenzymesPostmenopausemedicine.anatomical_structureEnzymeEndocrinologychemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesRaloxifene Hydrochloridecardiovascular systembiology.proteinCyclooxygenase 1PyrazolesFemaleCyclooxygenasebusinessmedicine.drugMenopause (New York, N.Y.)
researchProduct

Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease

2021

Fabry disease (FD) is a lysosomal storage disorder (LSD) characterized by lysosomal accumulation of glycosphingolipids in a wide variety of cytotypes, including endothelial cells (ECs). FD patients experience a significantly reduced life expectancy compared to the general population

SenescencePremature agingAdultMalesenescenceAdolescentPopulationsmall extracellular vesiclesUmbilical veinArticleAndrologyExtracellular VesiclesYoung AdultHUVECIn vivosmall extracellular vesicleHuman Umbilical Vein Endothelial CellsmiR-126-3pMedicineHumanseducationlcsh:QH301-705.5Cellular SenescenceAgedAged 80 and overSettore MED/04 - Patologia Generaleeducation.field_of_studySphingolipidsFabry diseasemicroRNAbusiness.industryagingAging PrematureGeneral MedicineMiddle Agedmedicine.diseaseFabry diseaseendothelial cellsMicroRNAslcsh:Biology (General)endothelial cellBiomarker (medicine)NanoparticlesFemaleGlycolipidsbusinessReactive Oxygen SpeciesEx vivoBiomarkersCells
researchProduct

Perinatal and Wharton's jelly-derived mesenchymal stem cells in cartilage regenerative medicine and tissue engineering strategies

2011

Stem cells can be found in embryonic and extraembryonic tissues as well as in adult organs. In particular, research in the last few years has delineated the key features of perinatal stem cells derived from fetus-associated tissues. These cells show multiple differentiation potential, can be easily expanded ex vivo, and raise no ethical concerns as regards their use. Several reports indicate that cells isolated from Wharton's jelly (WJ), the main component of umbilical cord extracellular matrix, are multipotent stem cells that express markers shared by other mesenchymal stem cells (MSC) and give rise to different mature cell types belonging to all three germ layers. Moreover, WJ-MSC display…

Settore BIO/16 - Anatomia UmanaMesenchymal stem cellClinical uses of mesenchymal stem cellsBiologyRegenerative medicineCell biologyDevelopmental NeuroscienceMultipotent Stem CellWharton's jellyImmunologyArticular cartilage Chondrocytes Differentiation markers Extracellular matrix Mesenchymal stem cells scaffolds Tissue engineering Umbilical cord Wharton’s jellyStem cellDevelopmental BiologyStem cell transplantation for articular cartilage repairAdult stem cell
researchProduct

Wharton's Jelly Mesenchymal Stem Cells and Immune Modulation: Regenerative Medicine Meets Tissue Repair

2013

Settore BIO/16 - Anatomia UmanaMesenchymal stem cellImmunologyWharton's jellyBiologyTissue repairImmune modulationRegenerative medicineWharton's jelly umbilical cord mesenchymal stem cells regenerative medicine immune modulation tissue repair differentiationCell biology
researchProduct

Umbilical cord revisited: From Wharton's jelly myofibroblasts to mesenchymal stem cells

2013

The umbilical cord (UC) is an essential part of the placenta, contributing to foetal development by ensuring the blood flow between mother and foetus. The UC is formed within the first weeks of gestation by the enclosure of the vessels (one vein and two arteries) into a bulk of mucous connective tissue, named Wharton's jelly (WJ) and lined by the umbilical epithelium. Since their first identification, cells populating WJ were described as unusual fibroblasts (or myofibroblasts). Recent literature data further highlighted the functional interconnection between UC and the resident cells. The UC represents a reservoir of progenitor populations which are collectively grouped into MSCs (mesenchy…

Settore BIO/16 - Anatomia UmanaPlacentaStem CellsBone Marrow CellsCell DifferentiationMesenchymal Stem CellsRegenerative MedicineExtracellular MatrixUmbilical CordPhenotypeUmbilical cord Wharton's jelly mesenchymal stem cells extracellular matrix immunomodulatory markers stromal myofibroblastsPregnancyAnimalsHumansFemaleWharton JellyMyofibroblasts
researchProduct

Isolation and phenotypical characterization of mesenchymal stem cells from the Wharton's jelly of pre-term human umbilical cord

2014

Settore BIO/16 - Anatomia UmanaUmbilical cord perinatal stem cells mesenchymal stem cells immune modulation isolation protocol cell culture markers
researchProduct

Wharton's jelly immunomodulatory properties and unique markers expression: new actors at play

2014

Settore BIO/16 - Anatomia UmanaUmbilical cord wharton's jelly MSC markers immunomodulatory.
researchProduct

Wharton's jelly mesencymal stem cells differentiated into hepatocyte-like cells show expression of immunomodulatory molecules

2014

Settore BIO/16 - Anatomia UmanaWharton's jelly mesenchymal stem cells umbilical cord cell therapy regenerative medicine immunomodulatory molecules
researchProduct

Characterization of the immunomodulatory properties of mesenchymal stem cells isolated from Wharton's jelly

2012

Settore BIO/16 - Anatomia UmanaWharton's jelly umbilical cord mesenchymal stem cells immune modulation regenerative medicine differentiation
researchProduct

A novel isolation technique and extended characte-rization of mesenchymal stem cells from human umbilical cord matrix: disclosing new potentials for …

2008

Settore BIO/16 - Anatomia Umanamesenchymal cells umbilical cord regenerative medicine immune regulation differentiation lineage markers
researchProduct